TREA

90322325 - CUREMARK

Follow

Information

  • Trademark
  • 90322325
  • Serial Number
    90322325
  • Registration Number
    6573013
  • Filing Date
    November 16, 2020
    3 years ago
  • Registration Date
    November 30, 2021
    2 years ago
  • Transaction Date
    August 26, 2022
    2 years ago
  • Status Date
    November 30, 2021
    2 years ago
  • Published for Opposition Date
    September 14, 2021
    3 years ago
  • Location Date
    November 30, 2021
    2 years ago
  • First Use Anywhere Date
    January 01, 2004
    20 years ago
  • First Use In Commerce Date
    January 01, 2004
    20 years ago
  • Status Code
    700
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    KUMIS, SCOTT N
  • Attorney Docket Number
    U2400-00073
    Attorney Name
    Nicole K. McLaughlin
    Law Office Assigned Location Code
    N90
  • Owners
Information
Mark Drawing Code
4000
Mark Identification
CUREMARK
Case File Statements
  • GS0051: Pharmaceutical preparations and substances for the diagnosis, treatment and prevention of viral, bacterial, fungal, parasitic metabolic, endocrine, hepatological, respiratory, nervous system, neurological, gastrointestinal, digestive, inflammatory, pulmonary, hormonal, dermatological, psychiatric, addictive, behavioral, infectious, addictive, musculoskeletal, cardiovascular, ophthalmic, cardiopulmonary, genitourinary, sexual dysfunction, oncological and immune system related diseases and disorders; pharmaceutical preparations for the treatment and prevention of Influenza, Coronaviruses, pancreatic deficiencies, gastrointestinal disease, internal malabsorption syndromes, Autism, Autism Spectrum Disorder, Attention Deficit Hyperactivity Disorder and Williams Syndrome; Antibacterial, antiviral and antifungal preparations for skin and wound healing; disinfectants and antiseptics; antimicrobial cleansers for sanitation purposes; Medical assays for testing of bodily fluids and tissues for testing of enzymes in humans; biological preparations for medical testing; diagnostic preparations for medical purposes; testing kits comprised of medical diagnostic reagents and assays for testing enzymes and body fluids for use in disease detection; medical diagnostic reagents and assays for testing of enzymes and body fluids; chemical preparations for medical testing; diagnostic biomarker reagents for medical testing; all the foregoing for the diagnosis and treatment of viral, bacterial, fungal, parasitic metabolic, endocrine, hepatological, respiratory, nervous system, neurological, gastrointestinal, digestive, inflammatory, pulmonary, hormonal, dermatological, psychiatric, addictive, behavioral, infectious, addictive, musculoskeletal, cardiovascular, ophthalmic, cardiopulmonary, genitourinary, sexual dysfunction, oncological and immune system related diseases and disorders
  • PM0001: CURE MARK
  • GS0441: Medical testing for diagnostic and treatment purposes; Medical consultations; medical testing for diagnostic treatment purposes in the fields of viral, bacterial, fungal, parasitic metabolic, endocrine, hepatological, respiratory, nervous system, neurological, gastrointestinal, digestive, inflammatory, pulmonary, hormonal, dermatological, psychiatric, addictive, behavioral, infectious, addictive, musculoskeletal, cardiovascular, ophthalmic, cardiopulmonary, genitourinary, sexual dysfunction, oncological and immune system related diseases and disorders; medical testing for diagnostic treatment and prevention of Influenza, Coronaviruses, pancreatic deficiencies, gastrointestinal disease, internal malabsorption syndromes, Autism, Autism Spectrum Disorder, Attention Deficit Hyperactivity Disorder and Williams Syndrome; Medical diagnostic testing, monitoring and reporting services; performing diagnosis of diseases; Health care services, namely, the administration of medical assays for the detection of enzymes in humans
  • GS0421: Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; medical and pharmaceutical research; Development of pharmaceuticals and medical devices for others; Providing temporary use of non-downloadable computer software that allows users to make determinations regarding neurological diseases, specifically baseline staging, data gathering and monitoring of early, middle and late stage neurological diseases; Design and development of medical assays for others; clinical research and development of treatments for viral, bacterial, fungal, parasitic metabolic, endocrine, hepatological, respiratory, nervous system, neurological, gastrointestinal, digestive, inflammatory, pulmonary, hormonal, dermatological, psychiatric, addictive, behavioral, infectious, addictive, musculoskeletal, cardiovascular, ophthalmic, cardiopulmonary, genitourinary, sexual dysfunction, oncological and immune system related diseases and disorders; clinical research and development of treatments for the treatment and prevention of Influenza, Coronaviruses, pancreatic deficiencies, gastrointestinal disease, internal malabsorption syndromes, Autism, Autism Spectrum Disorder, Attention Deficit Hyperactivity Disorder and Williams Syndrome; clinical research and development of treatments for antibacterial, antiviral, and antifungal preparations for skin and wound healing; clinical research and development of disinfectants, antiseptics and antimicrobial cleansers for sanitation purposes; medical and scientific research services in the field of digestion and detection of enzymes or biological substances in the body
Case File Event Statements
  • 11/30/2021 - 2 years ago
    21 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 9/14/2021 - 3 years ago
    20 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 9/14/2021 - 3 years ago
    19 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 8/26/2021 - 3 years ago
    18 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 8/6/2021 - 3 years ago
    17 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 7/12/2021 - 3 years ago
    16 - ASSIGNED TO EXAMINER Type: DOCK
  • 7/9/2021 - 3 years ago
    15 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 7/9/2021 - 3 years ago
    14 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 7/1/2021 - 3 years ago
    13 - ASSIGNED TO LIE Type: ALIE
  • 5/3/2021 - 3 years ago
    12 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN
  • 5/3/2021 - 3 years ago
    11 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 5/3/2021 - 3 years ago
    10 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 5/3/2021 - 3 years ago
    9 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 5/3/2021 - 3 years ago
    8 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR
  • 4/29/2021 - 3 years ago
    7 - TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Type: ERSI
  • 4/26/2021 - 3 years ago
    6 - NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Type: GNS3
  • 4/26/2021 - 3 years ago
    5 - LETTER OF SUSPENSION E-MAILED Type: GNSL
  • 4/26/2021 - 3 years ago
    4 - SUSPENSION LETTER WRITTEN Type: CNSL
  • 4/26/2021 - 3 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 1/15/2021 - 3 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS
  • 11/19/2020 - 3 years ago
    1 - NEW APPLICATION ENTERED IN TRAM Type: NWAP